Overview

Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate of efficacy and safety as H.pylori eradiation effect between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal ulcer patients with H.pylori positive infection.
Phase:
Phase 3
Details
Lead Sponsor:
Il-Yang Pharm. Co., Ltd.
Treatments:
Pantoprazole